chr1-181544731-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.513-33035A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.104 in 152,174 control chromosomes in the GnomAD database, including 1,049 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 1049 hom., cov: 32)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0490

Publications

3 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.254 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.513-33035A>G intron_variant Intron 3 of 47 ENST00000367573.7 NP_001192222.1 Q15878-1Q59FG1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.513-33035A>G intron_variant Intron 3 of 47 1 NM_001205293.3 ENSP00000356545.2 Q15878-1
CACNA1EENST00000360108.7 linkc.513-33035A>G intron_variant Intron 3 of 46 5 ENSP00000353222.3 F8W9Z1
CACNA1EENST00000367570.6 linkc.513-33035A>G intron_variant Intron 3 of 46 1 ENSP00000356542.1 Q15878-3
CACNA1EENST00000621791.4 linkc.513-33035A>G intron_variant Intron 3 of 45 1 ENSP00000481619.1 Q15878-2
CACNA1EENST00000524607.6 linkc.948-33035A>G intron_variant Intron 5 of 11 5 ENSP00000432038.2 E9PIE8

Frequencies

GnomAD3 genomes
AF:
0.104
AC:
15756
AN:
152056
Hom.:
1041
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0758
Gnomad AMI
AF:
0.0165
Gnomad AMR
AF:
0.162
Gnomad ASJ
AF:
0.0821
Gnomad EAS
AF:
0.258
Gnomad SAS
AF:
0.266
Gnomad FIN
AF:
0.0940
Gnomad MID
AF:
0.111
Gnomad NFE
AF:
0.0877
Gnomad OTH
AF:
0.109
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.104
AC:
15790
AN:
152174
Hom.:
1049
Cov.:
32
AF XY:
0.109
AC XY:
8124
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0762
AC:
3164
AN:
41526
American (AMR)
AF:
0.162
AC:
2482
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.0821
AC:
285
AN:
3472
East Asian (EAS)
AF:
0.258
AC:
1331
AN:
5164
South Asian (SAS)
AF:
0.266
AC:
1284
AN:
4826
European-Finnish (FIN)
AF:
0.0940
AC:
995
AN:
10584
Middle Eastern (MID)
AF:
0.112
AC:
33
AN:
294
European-Non Finnish (NFE)
AF:
0.0877
AC:
5968
AN:
68012
Other (OTH)
AF:
0.111
AC:
233
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
705
1409
2114
2818
3523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
188
376
564
752
940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0974
Hom.:
2514
Bravo
AF:
0.106
Asia WGS
AF:
0.234
AC:
810
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
2.1
DANN
Benign
0.28
PhyloP100
-0.049
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12024842; hg19: chr1-181513867; API